ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

2.46
-0.06
( -2.38% )
Updated: 09:20:38

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.46
Bid
2.45
Ask
2.47
Volume
10,366
2.45 Day's Range 2.52
1.25 52 Week Range 32.415
Market Cap
Previous Close
2.52
Open
2.52
Last Trade
100
@
2.46
Last Trade Time
09:20:40
Financial Volume
US$ 25,783
VWAP
2.4872
Average Volume (3m)
174,504
Shares Outstanding
28,874,513
Dividend Yield
-
PE Ratio
-0.94
Earnings Per Share (EPS)
-2.62
Revenue
-
Net Profit
-75.52M

About Aerovate Therapeutics Inc

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was US$2.52. Over the last year, Aerovate Therapeutics shares have traded in a share price range of US$ 1.25 to US$ 32.415.

Aerovate Therapeutics currently has 28,874,513 shares outstanding. The market capitalization of Aerovate Therapeutics is US$72.76 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -0.94.

AVTE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.4081632653062.452.572.4199672192.50184758CS
4002.462.572.33947742.42659144CS
12-0.12-4.65116279072.582.732.331745042.53054497CS
260.5226.80412371131.9431.844824282.46001154CS
52-22.21-90.02837454424.6732.4151.255737844.07957338CS
156-9.27-79.028132992311.7332.4151.252509017.61332402CS
260-25.54-91.21428571432832.4151.252226258.33130715CS

AVTE - Frequently Asked Questions (FAQ)

What is the current Aerovate Therapeutics share price?
The current share price of Aerovate Therapeutics is US$ 2.46
How many Aerovate Therapeutics shares are in issue?
Aerovate Therapeutics has 28,874,513 shares in issue
What is the market cap of Aerovate Therapeutics?
The market capitalisation of Aerovate Therapeutics is USD 72.76M
What is the 1 year trading range for Aerovate Therapeutics share price?
Aerovate Therapeutics has traded in the range of US$ 1.25 to US$ 32.415 during the past year
What is the PE ratio of Aerovate Therapeutics?
The price to earnings ratio of Aerovate Therapeutics is -0.94
What is the reporting currency for Aerovate Therapeutics?
Aerovate Therapeutics reports financial results in USD
What is the latest annual profit for Aerovate Therapeutics?
The latest annual profit of Aerovate Therapeutics is USD -75.52M
What is the registered address of Aerovate Therapeutics?
The registered address for Aerovate Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aerovate Therapeutics website address?
The website address for Aerovate Therapeutics is www.aerovatetx.com
Which industry sector does Aerovate Therapeutics operate in?
Aerovate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STISolidion Technology Inc
US$ 0.2269
(79.94%)
384.87M
CRVOCervoMed Inc
US$ 4.0394
(71.16%)
13.99M
VSTEVast Renewable Ltd
US$ 0.7469
(49.41%)
140.56M
SNCRSynchronoss Technologies Inc
US$ 9.70
(36.04%)
179.71k
OPRXOptimizeRx Corporation
US$ 5.62
(35.75%)
8.88M
ZYXIZynex Inc
US$ 3.94
(-43.71%)
298.92k
HEPAHepion Pharmaceuticals Inc
US$ 0.0499
(-40.60%)
25.59M
IRBTiRobot Corporation
US$ 3.8799
(-38.51%)
5.23M
APDNApplied DNA Sciences Inc
US$ 0.0931
(-36.67%)
5.5M
SYRSSyros Pharmaceuticals Inc
US$ 0.0866
(-36.32%)
9.78M
STISolidion Technology Inc
US$ 0.2269
(79.94%)
306.78M
VSTEVast Renewable Ltd
US$ 0.7469
(49.41%)
131.05M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.0362
(14.24%)
78.45M
NVDANVIDIA Corporation
US$ 114.51
(5.29%)
63.5M
AREBAmerican Rebel Holdings Inc
US$ 0.356
(17.14%)
43.87M